is one of India’s leading BI-monthly
Pharma journals, appropriately referred
to as the Umbrella Journal of the Pharma
Industry. With its high quality of
content, it is abstracted and Indexed by
the International Pharmaceutical
Abstracts & Chemical Abstracts-USA,
Index Copernicus-Poland and is listed in
Ulrich Database-USA. The journal
provides an excellent platform for
authors, researchers and advertisers.
Also available in user friendly flip
book digital format online and on CD
Rom, the journal has readership in many
countries, provides media support to
Pharma Expos and Conferences worldwide
and has a large number of advertisers
from India and overseas.
Receives FDA Fast Track Designation
for Evofosfamide for Treatment of
Patients Living With Advanced
Commercial Conflict of Interests
Justifiable in Medical Journals?
Pharma Sector Welcomes India's
Intellectual Property Policy
Co. Announces Multi-Year, World-Wide
PhysioPD™ Research Agreement with
Acquires Minority Interest in AM-Pharma;
Secures Option to Acquire Company
Biopsy' Using Blood Test is Latest
Weapon Against Cancer
Soon to Fix Heart Attack Tear?
Test Spots Tumors Earlier Than CT
countries across the globe have
established or are in the process of
establishing sound drug regulatory
systems in keeping with the need of
providing safe and cost effective
medication for their people....
Editorial Board of The Pharma Review
comprises of eminent pharma
personalities from India and abroad.
Review regularly conducts interviews of
a cross section of industry
personalities. To read more, click here.